Chemed CHE Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $74.52M-58.2% | $178.35M-32.4% | $263.96M+256% | $74.13M+125% | ||
| $182.58M+6.7% | $171.16M-5.7% | $181.51M+30.2% | $139.41M+1.6% | ||
| $7.54M-7.9% | $8.19M-31.7% | $12M+16.9% | $10.27M+1.6% | ||
| $302.62M-23.3% | $394.75M-21.2% | $500.84M+83.7% | $272.61M+18.4% | ||
| $205.66M+2.4% | $200.84M-1.5% | $203.84M+2.1% | $199.71M+3.1% | ||
| $667M0.0% | $666.74M+14.0% | $585.02M+0.6% | $581.3M+0.5% | ||
| $82.76M+260% | $23.01M-28.8% | $32.31M-23.4% | $42.15M-18.2% | ||
| $1.54B-7.8% | $1.67B0.0% | $1.67B+15.7% | $1.44B+7.4% | ||
| $64.46M+46.0% | $44.15M-31.1% | $64.03M+52.9% | $41.88M-42.6% | ||
| $287.13M+0.5% | $285.7M-8.4% | $312.05M+5.0% | $297.21M-1.7% | ||
| —— | —— | —— | $92.5M-50.0% | ||
| $558.78M+1.7% | $549.58M-1.9% | $560.22M-12.9% | $643.3M-10.6% | ||
| $80M0.0% | $80M0.0% | $80M0.0% | $80M0.0% | ||
| $2.96B+8.6% | $2.72B+11.2% | $2.45B+11.3% | $2.2B+11.6% | ||
| $979.41M-12.5% | $1.12B+1.0% | $1.11B+38.7% | $798.72M+28.1% | ||
| $1.54B-7.8% | $1.67B0.0% | $1.67B+15.7% | $1.44B+7.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Chemed cover its short-term obligations?
- Its current ratio is 0.85 — current liabilities exceed current assets.
- Where does Chemed's balance sheet data come from?
- Every line is extracted from Chemed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.